JP2024515697A - 再構成されていないt細胞受容体(tcr)遺伝子座を含む幹細胞及びその使用方法 - Google Patents
再構成されていないt細胞受容体(tcr)遺伝子座を含む幹細胞及びその使用方法 Download PDFInfo
- Publication number
- JP2024515697A JP2024515697A JP2023564480A JP2023564480A JP2024515697A JP 2024515697 A JP2024515697 A JP 2024515697A JP 2023564480 A JP2023564480 A JP 2023564480A JP 2023564480 A JP2023564480 A JP 2023564480A JP 2024515697 A JP2024515697 A JP 2024515697A
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- stem
- progenitor
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
- A61K40/32—T-cell receptors [TCR]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2307—Interleukin-7 (IL-7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163178990P | 2021-04-23 | 2021-04-23 | |
| US63/178,990 | 2021-04-23 | ||
| PCT/CA2022/050622 WO2022221962A1 (en) | 2021-04-23 | 2022-04-22 | Stem cells comprising an unrearranged t cell receptor (tcr) gene locus and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515697A true JP2024515697A (ja) | 2024-04-10 |
| JP2024515697A5 JP2024515697A5 (cg-RX-API-DMAC10.html) | 2025-04-30 |
Family
ID=83723544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564480A Pending JP2024515697A (ja) | 2021-04-23 | 2022-04-22 | 再構成されていないt細胞受容体(tcr)遺伝子座を含む幹細胞及びその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240209314A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4326856A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024515697A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117480249A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3216417A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022221962A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3091158A1 (en) | 2018-02-14 | 2019-08-22 | Sunnybrook Research Institute | Method for generating cells of the t cell lineage |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016010148A1 (ja) * | 2014-07-18 | 2016-01-21 | 国立大学法人京都大学 | 多能性幹細胞から免疫細胞療法用t細胞を誘導する方法 |
| WO2018183823A1 (en) * | 2017-03-31 | 2018-10-04 | Hera Testing Laboratories, Inc. | Novel immunodeficient rat for modeling human cancer |
-
2022
- 2022-04-22 EP EP22790648.4A patent/EP4326856A4/en active Pending
- 2022-04-22 US US18/287,970 patent/US20240209314A1/en active Pending
- 2022-04-22 CN CN202280042484.9A patent/CN117480249A/zh active Pending
- 2022-04-22 JP JP2023564480A patent/JP2024515697A/ja active Pending
- 2022-04-22 WO PCT/CA2022/050622 patent/WO2022221962A1/en not_active Ceased
- 2022-04-22 CA CA3216417A patent/CA3216417A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016010148A1 (ja) * | 2014-07-18 | 2016-01-21 | 国立大学法人京都大学 | 多能性幹細胞から免疫細胞療法用t細胞を誘導する方法 |
| WO2018183823A1 (en) * | 2017-03-31 | 2018-10-04 | Hera Testing Laboratories, Inc. | Novel immunodeficient rat for modeling human cancer |
Non-Patent Citations (1)
| Title |
|---|
| RAQUEL GAGO-FUENTES ET AL.: "Normal development of mice lacking PAXX, the paralogue of XRCC4 and XLF", FEBS OPEN BIO., vol. 8, no. 3, JPN6026025062, 2018, pages 426 - 434, ISSN: 0005885707 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20240209314A1 (en) | 2024-06-27 |
| CA3216417A1 (en) | 2022-10-27 |
| WO2022221962A1 (en) | 2022-10-27 |
| EP4326856A1 (en) | 2024-02-28 |
| CN117480249A (zh) | 2024-01-30 |
| EP4326856A4 (en) | 2025-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7560502B2 (ja) | 多能性幹細胞からhlaホモ接合免疫細胞への指向分化方法 | |
| EP3612557B1 (en) | Antigen-specific immune effector cells | |
| JP2023507118A (ja) | 治療のための操作された細胞 | |
| KR20180063333A (ko) | 면역 세포로의 만능 줄기 세포의 지정된 분화 방법 | |
| CA3091136A1 (en) | Method for producing low-antigenic cell | |
| CN114292817A (zh) | 从多能性干细胞诱导细胞免疫治疗用t细胞的方法 | |
| US20260097074A1 (en) | Erythroid lineages derived from pluripotent cells | |
| WO2022221962A1 (en) | Stem cells comprising an unrearranged t cell receptor (tcr) gene locus and methods of use thereof | |
| US20250368955A1 (en) | B cell lineages derived from pluripotent cells | |
| US20250332260A1 (en) | Immune compatible cells for allogeneic cell therapies to cover global, ethnic, or disease-specific populations | |
| US20080112933A1 (en) | Methods and Compositions for Increasing Stem Cell Homing Using Gas Activators | |
| HK40085019A (en) | Genomic engineering of pluripotent cells | |
| KR20250099776A (ko) | 만능 줄기세포 유래 t 세포 집단 및 이의 전구체 | |
| HK1258739B (en) | Genomic engineering of pluripotent cells | |
| HK1258739A1 (zh) | 多能细胞的基因组工程改造 | |
| EA046022B1 (ru) | Антигенспецифические иммунные эффекторные клетки |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240507 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250421 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250421 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260616 |